Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | NPC1 | O15118 | 2/20 | 1.00 |
| ▸ | RAB9A | P51151 | 1/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 6/20 | 0.82 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.75 |
| ▸ | MAPT | P10636 | 3/20 | 0.75 |
| ▸ | TP53 | P04637 | 2/20 | 0.75 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.75 |
| ▸ | HPGD | P15428 | 2/20 | 0.74 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.74 |
| ▸ | AR | P10275 | 2/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.73 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.73 |
| ▸ | TSHR | P16473 | 1/20 | 0.73 |
| ▸ | PPARG | P37231 | 1/20 | 0.73 |
| ▸ | CCNC | P24863 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chrysin Dimethyl Ether SCHEMBL29403280 | 1.00 | ABCG2 (1.00) | ABCG2ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL31238392 | 0.91 | KDM4E (0.83) | ABCG2ALDH1A1KDM4EMEN1KMT2A | |
| Trimethylapigenin SCHEMBL29350875 | 0.90 | ABCB1 (1.00) | ABCG2ALDH1A1KDM4EMEN1KMT2A | |
| Trimethylapigenin SCHEMBL1421585 | 0.90 | ABCB1 (1.00) | ABCG2ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL20100898 | 0.87 | KDM4E (0.78) | ABCG2ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL4051739 | 0.87 | KDM4E (0.78) | ABCG2ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL4165061 | 0.87 | ABCB1 (0.81) | ABCG2ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL19235588 | 0.86 | ALDH1A1 (0.76) | ABCG2ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL311530 | 0.86 | ABCB1 (0.82) | ABCG2ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL22667395 | 0.86 | ABCB1 (0.82) | ABCG2ALDH1A1KDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 279 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115248-A1 | METHOD FOR PRODUCING BLACK GINGER EXTRACT AND METHOD FOR PRODUCING COMPOSITION | MARUZEN PHARM CO LTD (JP) | 2026-04-30 | — | — | US | claimed |
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECH INC (US) | 2026-04-09 | — | — | US | claimed |
| EP-4496476-A1 | GAS PHASE TREATMENT OF PRODUCE | Apeel Technology, Inc. (US) | 2025-01-29 | — | — | EP | claimed |
| CN-119156138-A | Vapor treatment of agricultural products | 阿比尔技术公司 | 2024-12-17 | — | — | CN | claimed |
| CN-111971042-B | Granulin for identifying as causative agent of Alzheimer's disease, composition and method for inhibiting aggregation of granulin and treating Alzheimer's disease | 刘承铉 | 2024-01-02 | — | — | CN | claimed |
| CN-117320559-A | Edible coating with antimicrobial properties | 阿比尔技术公司 | 2023-12-29 | — | — | CN | claimed |
| CN-117233298-A | Metabolic-chemistry-based exocarpium citri rubrum year identification method | 中国检验检疫科学研究院 | 2023-12-15 | — | — | CN | claimed |
| WO-2023183341-A1 | GAS PHASE TREATMENT OF PRODUCE | APEEL TECHNOLOGY, INC. (US) | 2023-09-28 | — | — | WO | claimed |
| US-20230021051-A1 | Composition Containing Black Ginger Extract and Composition for Oral Administration | MARUZEN PHARMACEUTICALS CO., LTD. (JP) | 2023-01-19 | — | — | US | claimed |
| CN-115475157-A | Intestinal barrier improving agent | 株式会社资生堂 | 2022-12-16 | — | — | CN | claimed |
| US-20150209324-A1 | USE OF FLAVONE COMPOUND FOR PREVENTION OR TREATMENT OF OBESITY | AAT COSTECH CO., LTD. (KR) | 2015-07-30 | — | — | US | claimed |
| US-20150190452-A1 | USE OF KAEMPFERIA PARVIFLORA WALL. EX. BAKER EXTRACTS OR FLAVONE COMPOUND FOR PREVENTING OR TREATING MUSCLE DISEASES, OR IMPROVING MUSCLE FUNCTION | AAT COSTECH CO., LTD. (KR) | 2015-07-09 | — | — | US | claimed |
| EP-2851071-A1 | USE OF KAEMPFERIA PARVIFLORA WALL. EX. BAKER EXTRACTS OR FLAVONE COMPOUND FOR PREVENTING OR TREATING MUSCLE DISEASES, OR IMPROVING MUSCLE FUNCTION | Industry-Academic Cooperation Foundation Yonsei University (KR) | 2015-03-25 | — | — | EP | claimed |
| EP-2851072-A1 | USE OF FLAVONE COMPOUND FOR PREVENTION OR TREATMENT OF OBESITY | Industry-Academic Cooperation Foundation Yonsei University (KR) | 2015-03-25 | — | — | EP | claimed |
| WO-2011058423-A2 | IDENTIFICATION AND CHARACTERIZATION OF NATURAL CHEMICAL ENTITIES BY LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY LC-MS/MS AND USES THEREOF | AVESTHAGEN LIMITED (IN) | 2011-05-19 | — | — | WO | claimed |
| US-6872771-B1 | Tire with rubber containing flavone | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2005-03-29 | — | — | US | claimed |
| JP-2003504327-A | — | — | 2003-02-04 | — | — | JP | claimed |
| EP-1223928-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | Prendergast, Patrick Thomas (IE) | 2002-07-24 | — | — | EP | claimed |
| WO-2001003681-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | PRENDERGAST PATRICK T (IE) | 2001-01-18 | — | — | WO | claimed |
| US-5399584-A | Preventing gastrointestinal damage caused by nonsteroidal antiinflammatory drugs | THE PROCTER & GAMBLE COMPANY (US) | 1995-03-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115248-A1 | METHOD FOR PRODUCING BLACK GINGER EXTRACT AND METHOD FOR PRODUCING COMPOSITION | CYP4F8, CYP4F2, CYP4F11 | ABCG2 75/4885ALDH1A1 2175/4885KDM4E 2527/4885 |
| US-20230021051-A1 | Composition Containing Black Ginger Extract and Composition for Oral Administration | CYP4F8, CYP4F2, CYP4F11 | ABCG2 125/4885ALDH1A1 1366/4885KDM4E 2274/4885 |
| US-20150209324-A1 | USE OF FLAVONE COMPOUND FOR PREVENTION OR TREATMENT OF OBESITY | FABP4, SREBF1, SREBF2 | ABCG2 2205/4885ALDH1A1 799/4885KDM4E 301/4885 |
| US-20150190452-A1 | USE OF KAEMPFERIA PARVIFLORA WALL. EX. BAKER EXTRACTS OR FLAVONE COMPOUND FOR PREVENTING OR TREATING MUSCLE DISEASES, OR IMPROVING MUSCLE FUNCTION | MYOF, PYGM, PKM | ABCG2 4012/4885ALDH1A1 4285/4885KDM4E 193/4885 |
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | CYP51A1, ERG28, NISCH | ABCG2 1895/4885ALDH1A1 1286/4885KDM4E 1123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.